Provided by Tiger Trade Technology Pte. Ltd.

Terns Pharmaceuticals, Inc.

41.38
-0.0700-0.17%
Volume:2.27M
Turnover:94.06M
Market Cap:4.51B
PE:-40.10
High:42.13
Open:41.15
Low:40.84
Close:41.45
52wk High:48.26
52wk Low:1.87
Shares:109.00M
Float Shares:80.32M
Volume Ratio:1.57
T/O Rate:2.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0319
EPS(LYR):-1.1175
ROE:-29.12%
ROA:-19.94%
PB:15.88
PE(LYR):-37.03

Loading ...

Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Jul 30, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jul 18, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jul 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
Apr 30, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities